CymaBay Therapeutics scraps two studies of liver drug; shares plunge
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients,…
New Roche flu drug can drive resistance in influenza viruses: researchers
CHICAGO (Reuters) – Roche’s influenza treatment Xofluza, a one-dose pill that can clear flu symptoms within days, may cause a mutation of the virus that leads to drug resistance, researchers…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12…
French doctor still treating patients at 98
CHEVILLY-LARUE, France (Reuters) – When French doctor Christian Chenay saw his first patients in 1951, penicillin was state of the art. French doctor Christian Chenay, 98 years-old, treats a patient…
Exclusive: UniCredit clinches deal to cut exposure to Turkish lender Yapi Kredi – sources
ISTANBUL/LONDON/MILAN (Reuters) – UniCredit (CRDI.MI) has struck a deal to reduce its exposure to Turkey’s Yapi Kredi (YKBNK.IS), three sources told Reuters, a move seen as a first step toward…
Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ
FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Swiss drugmaker Novartis AG…
France’s LVMH close to buying Tiffany after sweetening offer: sources
(Reuters) – LVMH (LVMH.PA) is close to buying U.S. jewelry chain Tiffany & Co (TIF.N) for about $16.3 billion after sweetening its offer, sources said on Sunday, as the owner…
Finnair cancels 276 flights as unions join solidarity strike
HELSINKI (Reuters) – Finland’s national airline Finnair (FIA1S.HE) said on Sunday it was forced to cancel 276 flights scheduled for Sunday and Monday after attempts to settle a labor dispute…
Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion
ZURICH (Reuters) – Novartis AG (NOVN.S) is buying U.S. biotechnology company The Medicines Co (MDCO.O) for about $9.7 billion, the Swiss drugmaker said on Sunday, as it seeks to expand…
France’s 5G spectrum to be sold at floor price of 2.17 billion euros: minister
French Junior Economy Minister Agnes Pannier-Runacher poses after an interview with Reuters in Paris, France, October 15, 2019. REUTERS/Benoit Tessier PARIS (Reuters) – Frances’s 5G spectrum will be sold at…